Seeking Alpha

Oculus Innovative Sciences (OCLS) says its partner Dyamed Biotech is initiating rollout of five...

Oculus Innovative Sciences (OCLS) says its partner Dyamed Biotech is initiating rollout of five new Microcyn Technology-based products in Singapore and Malaysia, both in the hospital and consumer markets. The five products, which include Dermacyn BabyGuard, Dermacyn DermaGuard, Dermacyn SkinGuard Solution, Dermacyn SkinGuard Hydrogel and Dermacyn Wound Care Hydrogel, will be rolled out sequentially with all products commercialized by year's end.
From other sites
Comments (1)
  • Joe2922
    , contributor
    Comments (421) | Send Message
     
    Lock & Load shares of OCLS
    10 Apr 2013, 03:06 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs